文献速递心境障碍

接受电休克治疗的重度抑郁发作患者全基因组关联研究

Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive therapy.
PubMed 文献 · Mol Psychiatry · 2021-01-22

该研究对2725例因重度抑郁发作接受电休克治疗的患者和4035例对照进行全基因组SNP基因分型,其中1796例符合窄定义(MDD背景下的MDE)。结果显示窄定义病例的SNP遗传力为29-34%,远高于PGC最新MDD研究的6.5-8.0%,并发现HLA-B内含子一个全基因组显著位点。

要点

  • 接受ECT的重度MDE患者SNP遗传力为29-34%,高于轻中度MDD的6.5-8.0%。
  • 重度MDE与神经发育障碍和神经质的遗传相关性低于PGC MDD,但双相障碍遗传风险评分高于iCBT MDD。
  • 发现一个全基因组显著位点rs114583506(P=5e-8),位于6号染色体HLA-B内含子。

核心结论

  • 接受ECT的重度MDE患者常见变异风险位点负荷高于轻中度MDD患者。
  • 重度MDE与其他严重成人起病精神障碍关系更强,与人格和应激相关特质关系弱于轻中度MDD。
  • 最重端抑郁发作可能具有不同的遗传架构,支持将最重MDD作为极端表型进一步研究。

研究设计与样本

  • 对2725例因重度抑郁发作接受ECT的病例和4035例对照进行全基因组SNP基因分型。
  • 其中1796例符合窄病例定义,即MDD背景下发生的MDE。
  • 采用标准GWAS质控和填充流程,并用连锁不平衡得分回归估计SNP遗传力和遗传相关性。

主要发现

  • 窄定义病例的SNP遗传力估计为29-34%(SE:6%)。
  • PGC最新MDD研究的SNP遗传力估计为6.5-8.0%。
  • 重度MDE与神经发育障碍和神经质的遗传相关性小于PGC MDD病例。
  • 重度MDE的双相障碍遗传风险评分高于iCBT MDD病例。
  • 发现一个全基因组显著位点rs114583506(P=5e-8),位于6号染色体主要组织相容性复合体区域HLA-B内含子。

关键数值与推荐

  • 窄病例定义为MDD背景下发生的MDE。
  • SNP遗传力采用连锁不平衡得分回归估计。
  • 全基因组显著位点判定标准为P=5e-8。

临床怎么用

  • 对接受ECT的重度MDE患者可考虑其具有更高的常见变异遗传负荷。
  • 临床评估重度MDE时需注意其与双相障碍等严重成人起病精神障碍的遗传关联更强。
  • 重度MDE的遗传架构不同于轻中度MDD,提示极端表型策略有助于理解MDD病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although large genome-wide association studies (GWAS) of major depressive disorder (MDD) have identified many significant loci, the SNP-based heritability remains notably low, which might be due to etiological heterogeneity in existing samples. Here, we test the utility of targeting the severe end of the MDD spectrum through genome-wide SNP genotyping of 2725 cases who received electroconvulsive therapy (ECT) for a major depressive episode (MDE) and 4035 controls. A subset of cases (n = 1796) met a narrow case definition (MDE occurring in the context of MDD). Standard GWAS quality control procedures and imputation were conducted. SNP heritability and genetic correlations with other traits were estimated using linkage disequilibrium score regression. Results were compared with MDD cases of mild-moderate severity receiving internet-based cognitive behavioral therapy (iCBT) and summary results from the Psychiatric Genomics Consortium (PGC). The SNP-based heritability was estimated at 29-34% (SE: 6%) for the narrow case definition, considerably higher than the 6.5-8.0% estimate in the most recent PGC MDD study. Our severe MDE cases had smaller genetic correlations with neurodevelopmental disorders and neuroticism than PGC MDD cases but higher genetic risk scores for bipolar disorder than iCBT MDD cases. One genome-wide significant locus was identified (rs114583506, P = 5e-8) in an intron of HLA-B in the major histocompatibility locus on chr6. These results indicate that individuals receiving ECT for an MDE have higher burden of common variant risk loci than individuals with mild-moderate MDD. Furthermore, severe MDE shows stronger relations with other severe adult-onset psychiatric disorders but weaker relations with personality and stress-related traits than mild-moderate MDD. These findings suggest a different genetic architecture at the severest end of the spectrum, and support further study of the severest MDD cases as an extreme phenotype approach to understand the etiology of MDD.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Clements CC, Karlsson R, Lu Y, et al. Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive therapy. Mol Psychiatry. 2021. PMID: 33483693. doi:10.1038/s41380-020-00984-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。